Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study
Alessandro Crotta(European Organisation for Rare Diseases), Franco Locatelli(Bambino Gesù Children's Hospital), Margaret L. MacMillan(University of Minnesota Medical Center), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Jerry Stein(Schneider Children's Medical Center), Mohamad Mohty(Sorbonne Université), Lochie Teague(Starship Children's Health), Adrienne B.M. Madureira(Instituto Nacional de Câncer - INCA), Mary Eapen(Medical College of Wisconsin), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Marco Zecca(Policlinico San Matteo Fondazione), Tracey O’Brien(Sydney Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Ajay Vora(Great Ormond Street Hospital), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), John E. Wagner(Kings County Hospital Center), Charlotte M. Niemeyer(University of Freiburg), Vanderson Rocha(Fundação Pró-Sangue Hemocentro de São Paulo), Carmen Bonfim(Hospital de Clínicas Universidade Federal do Paraná), Joanne Kurtzberg
Cited by 2
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859